Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,666
archived clinical trials in
Hospital

An Exploratory Study to Evaluate Two Acupuncture Methods for the Treatment of Headaches Associated With Traumatic Brain Injury
A Randomized Exploratory Study to Evaluate Two Acupuncture Methods for the Treatment of Headaches Associated With Traumatic Brain Injury
Status: Enrolling
Updated:  3/19/2015
Fort Belvoir Community Hospital
mi
from
Alexandria, VA
An Exploratory Study to Evaluate Two Acupuncture Methods for the Treatment of Headaches Associated With Traumatic Brain Injury
A Randomized Exploratory Study to Evaluate Two Acupuncture Methods for the Treatment of Headaches Associated With Traumatic Brain Injury
Status: Enrolling
Updated: 3/19/2015
Fort Belvoir Community Hospital
mi
from
Alexandria, VA
Click here to add this to my saved trials
Use Of Oral Fidaxomicin Vs. Oral Vancomycin For Clostridium Difficile Infection In Patients With Spinal Cord Injury
Role of Fidaxomicin in a Patient Population With Problematic Clostridium Difficile Infection
Status: Enrolling
Updated:  3/27/2015
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Use Of Oral Fidaxomicin Vs. Oral Vancomycin For Clostridium Difficile Infection In Patients With Spinal Cord Injury
Role of Fidaxomicin in a Patient Population With Problematic Clostridium Difficile Infection
Status: Enrolling
Updated: 3/27/2015
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Clinical Trial of a Rehabilitation Game - SuperBetter
Clinical Trial of a Novel Rehabilitation Game (Phase I - Feasibility)
Status: Enrolling
Updated:  4/9/2015
The Ohio State University Physical Medicine and Rehabilitation Department
mi
from
Columbus, OH
Clinical Trial of a Rehabilitation Game - SuperBetter
Clinical Trial of a Novel Rehabilitation Game (Phase I - Feasibility)
Status: Enrolling
Updated: 4/9/2015
The Ohio State University Physical Medicine and Rehabilitation Department
mi
from
Columbus, OH
Click here to add this to my saved trials
Ranolazine and Microvascular Angina by PET in the Emergency Department
Ranolazine and Microvascular Angina by PET in the Emergency Department (RAMP-ED)
Status: Enrolling
Updated:  4/15/2015
Yale-New Haven Hospital
mi
from
New Haven, CT
Ranolazine and Microvascular Angina by PET in the Emergency Department
Ranolazine and Microvascular Angina by PET in the Emergency Department (RAMP-ED)
Status: Enrolling
Updated: 4/15/2015
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients
See Detailed Description
Status: Enrolling
Updated:  4/15/2015
GSK Investigational Site
mi
from
Long Beach, CA
Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients
See Detailed Description
Status: Enrolling
Updated: 4/15/2015
GSK Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients
See Detailed Description
Status: Enrolling
Updated:  4/15/2015
GSK Investigational Site
mi
from
Cleveland, OH
Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients
See Detailed Description
Status: Enrolling
Updated: 4/15/2015
GSK Investigational Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients
See Detailed Description
Status: Enrolling
Updated:  4/15/2015
GSK Investigational Site
mi
from
Philadelphia, PA
Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients
See Detailed Description
Status: Enrolling
Updated: 4/15/2015
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Clinical Use of Baxter Animated Retching Faces (BARF) Scale in Children
Clinical Use of Baxter Animated Retching Faces (BARF) Scale in Children
Status: Enrolling
Updated:  4/20/2015
Texas Children't Hospital
mi
from
Houston, TX
Clinical Use of Baxter Animated Retching Faces (BARF) Scale in Children
Clinical Use of Baxter Animated Retching Faces (BARF) Scale in Children
Status: Enrolling
Updated: 4/20/2015
Texas Children't Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Determination of Anatomic Variations of the Internal Jugular and Femoral Veins Using Ultrasound in the Emergency Department
Determination of Anatomic Variations of the Internal Jugular and Femoral Veins Using Ultrasound in the Emergency Department
Status: Enrolling
Updated:  4/29/2015
Tampa General Hospital
mi
from
Tampa, FL
Determination of Anatomic Variations of the Internal Jugular and Femoral Veins Using Ultrasound in the Emergency Department
Determination of Anatomic Variations of the Internal Jugular and Femoral Veins Using Ultrasound in the Emergency Department
Status: Enrolling
Updated: 4/29/2015
Tampa General Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
Molecular Markers of Neuroplasticity During Exercise in People With Incomplete Spinal Cord Injury
Molecular Markers of Neuroplasticity During High-Intensity Exercise in Subjects With Incomplete Spinal Cord Injury
Status: Enrolling
Updated:  5/15/2015
Rehabiliation Institute of Chicago
mi
from
Chicago, IL
Molecular Markers of Neuroplasticity During Exercise in People With Incomplete Spinal Cord Injury
Molecular Markers of Neuroplasticity During High-Intensity Exercise in Subjects With Incomplete Spinal Cord Injury
Status: Enrolling
Updated: 5/15/2015
Rehabiliation Institute of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
SurgiQuest AirSeal in Robotic Partial Nephrectomy - (TARPAN Study)
A Physician Preference Study of the Use of SurgiQuest AirSeal vs. Conventional Insufflation Systems for the Management of Pneumoperitoneum in Robotic Partial Nephrectomy .
Status: Enrolling
Updated:  5/24/2015
Washington University School of Medicine
mi
from
Saint Louis, MO
SurgiQuest AirSeal in Robotic Partial Nephrectomy - (TARPAN Study)
A Physician Preference Study of the Use of SurgiQuest AirSeal vs. Conventional Insufflation Systems for the Management of Pneumoperitoneum in Robotic Partial Nephrectomy .
Status: Enrolling
Updated: 5/24/2015
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
SurgiQuest AirSeal in Robotic Partial Nephrectomy - (TARPAN Study)
A Physician Preference Study of the Use of SurgiQuest AirSeal vs. Conventional Insufflation Systems for the Management of Pneumoperitoneum in Robotic Partial Nephrectomy .
Status: Enrolling
Updated:  5/24/2015
NYU Langone Medical Center
mi
from
New York, NY
SurgiQuest AirSeal in Robotic Partial Nephrectomy - (TARPAN Study)
A Physician Preference Study of the Use of SurgiQuest AirSeal vs. Conventional Insufflation Systems for the Management of Pneumoperitoneum in Robotic Partial Nephrectomy .
Status: Enrolling
Updated: 5/24/2015
NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
SurgiQuest AirSeal in Robotic Partial Nephrectomy - (TARPAN Study)
A Physician Preference Study of the Use of SurgiQuest AirSeal vs. Conventional Insufflation Systems for the Management of Pneumoperitoneum in Robotic Partial Nephrectomy .
Status: Enrolling
Updated:  5/24/2015
Swedish Medical Center
mi
from
Seattle, WA
SurgiQuest AirSeal in Robotic Partial Nephrectomy - (TARPAN Study)
A Physician Preference Study of the Use of SurgiQuest AirSeal vs. Conventional Insufflation Systems for the Management of Pneumoperitoneum in Robotic Partial Nephrectomy .
Status: Enrolling
Updated: 5/24/2015
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Pharmacokinetics of Low Dose Ketamine Infusion
Phase I Trial to Determine Steady State Pharmacokinetics and Sedative Effects of Low Dose Ketamine Infusion
Status: Enrolling
Updated:  6/8/2015
Children's Medical Center Dallas, University of Texas Southwestern
mi
from
Dallas, TX
Pharmacokinetics of Low Dose Ketamine Infusion
Phase I Trial to Determine Steady State Pharmacokinetics and Sedative Effects of Low Dose Ketamine Infusion
Status: Enrolling
Updated: 6/8/2015
Children's Medical Center Dallas, University of Texas Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
Evaluating Myocardial Injury for Defibrillation Threshold Testing Methods for ICD Implantation
Evaluating Myocardial Injury During ICD Implantation Using the Upper Limit of Vulnerability (ULV) Method vs. Standard Defibrillation Threshold Testing
Status: Enrolling
Updated:  6/17/2015
UCSD Sulpizio Cardiovascular Center
mi
from
La Jolla, CA
Evaluating Myocardial Injury for Defibrillation Threshold Testing Methods for ICD Implantation
Evaluating Myocardial Injury During ICD Implantation Using the Upper Limit of Vulnerability (ULV) Method vs. Standard Defibrillation Threshold Testing
Status: Enrolling
Updated: 6/17/2015
UCSD Sulpizio Cardiovascular Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Modulation of Molecular Fingerprinting in Pediatric Sepsis
Modulation of Molecular Fingerprinting in Pediatric Sepsis
Status: Enrolling
Updated:  6/29/2015
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Modulation of Molecular Fingerprinting in Pediatric Sepsis
Modulation of Molecular Fingerprinting in Pediatric Sepsis
Status: Enrolling
Updated: 6/29/2015
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated:  7/1/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated: 7/1/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated:  7/1/2015
Clinical Research Facility
mi
from
Jacksonville, FL
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated: 7/1/2015
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated:  7/1/2015
Clinical Research Facility
mi
from
Honolulu, HI
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated: 7/1/2015
Clinical Research Facility
mi
from
Honolulu, HI
Click here to add this to my saved trials
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated:  7/1/2015
Clinical Research Facility
mi
from
Topeka, KA
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated: 7/1/2015
Clinical Research Facility
mi
from
Topeka, KA
Click here to add this to my saved trials
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated:  7/1/2015
Clinical Research Facility
mi
from
Baltimore, MD
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated: 7/1/2015
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated:  7/1/2015
Clinical Research Facility
mi
from
Ann Arbor, MI
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated: 7/1/2015
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated:  7/1/2015
Clinical Research Facility
mi
from
Brooklyn, NY
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated: 7/1/2015
Clinical Research Facility
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated:  7/1/2015
Clinical Research Facility
mi
from
New York, NY
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated: 7/1/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated:  7/1/2015
Clinical Research Facility
mi
from
Durham, NC
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated: 7/1/2015
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated:  7/1/2015
Clinical Research Facility
mi
from
Memphis, TN
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated: 7/1/2015
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated:  7/1/2015
Clinical Research Facility
mi
from
Houston, TX
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated: 7/1/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated:  7/1/2015
Clinical Research Facility
mi
from
San Antonio, TX
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated: 7/1/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated:  7/1/2015
mi
from
Herston,
Primovist / Eovist in Renally Impaired Patients
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Status: Enrolling
Updated: 7/1/2015
mi
from
Herston,
Click here to add this to my saved trials
Work Injury Prevention in Law Enforcement Officials
Effectiveness of an Exercise-based Work Injury Prevention Program in Law Enforcement Officials
Status: Enrolling
Updated:  7/1/2015
Butte Premier Physical Therapy
mi
from
Chico, CA
Work Injury Prevention in Law Enforcement Officials
Effectiveness of an Exercise-based Work Injury Prevention Program in Law Enforcement Officials
Status: Enrolling
Updated: 7/1/2015
Butte Premier Physical Therapy
mi
from
Chico, CA
Click here to add this to my saved trials
Work Injury Prevention in Law Enforcement Officials
Effectiveness of an Exercise-based Work Injury Prevention Program in Law Enforcement Officials
Status: Enrolling
Updated:  7/1/2015
Physical Edge
mi
from
Davis, CA
Work Injury Prevention in Law Enforcement Officials
Effectiveness of an Exercise-based Work Injury Prevention Program in Law Enforcement Officials
Status: Enrolling
Updated: 7/1/2015
Physical Edge
mi
from
Davis, CA
Click here to add this to my saved trials
Work Injury Prevention in Law Enforcement Officials
Effectiveness of an Exercise-based Work Injury Prevention Program in Law Enforcement Officials
Status: Enrolling
Updated:  7/1/2015
Lodi Physical Therapy
mi
from
Lodi, CA
Work Injury Prevention in Law Enforcement Officials
Effectiveness of an Exercise-based Work Injury Prevention Program in Law Enforcement Officials
Status: Enrolling
Updated: 7/1/2015
Lodi Physical Therapy
mi
from
Lodi, CA
Click here to add this to my saved trials
Work Injury Prevention in Law Enforcement Officials
Effectiveness of an Exercise-based Work Injury Prevention Program in Law Enforcement Officials
Status: Enrolling
Updated:  7/1/2015
PUMP Institute
mi
from
Lodi, CA
Work Injury Prevention in Law Enforcement Officials
Effectiveness of an Exercise-based Work Injury Prevention Program in Law Enforcement Officials
Status: Enrolling
Updated: 7/1/2015
PUMP Institute
mi
from
Lodi, CA
Click here to add this to my saved trials
Work Injury Prevention in Law Enforcement Officials
Effectiveness of an Exercise-based Work Injury Prevention Program in Law Enforcement Officials
Status: Enrolling
Updated:  7/1/2015
University of the Pacific
mi
from
Stockton, CA
Work Injury Prevention in Law Enforcement Officials
Effectiveness of an Exercise-based Work Injury Prevention Program in Law Enforcement Officials
Status: Enrolling
Updated: 7/1/2015
University of the Pacific
mi
from
Stockton, CA
Click here to add this to my saved trials
Inflammation in Type 2 Myocardial Infarction
Inflammation in Type 2 Myocardial Infarction
Status: Enrolling
Updated:  7/1/2015
Bellevue Hospital Center
mi
from
New York, NY
Inflammation in Type 2 Myocardial Infarction
Inflammation in Type 2 Myocardial Infarction
Status: Enrolling
Updated: 7/1/2015
Bellevue Hospital Center
mi
from
New York, NY
Click here to add this to my saved trials
Inhalation Intervention for Nausea in the Emergency Department
Inhalation Intervention for Nausea in the Emergency Department
Status: Enrolling
Updated:  7/3/2015
Emergency Department, Brooke Army Medical Center
mi
from
Fort Sam Houston, TX
Inhalation Intervention for Nausea in the Emergency Department
Inhalation Intervention for Nausea in the Emergency Department
Status: Enrolling
Updated: 7/3/2015
Emergency Department, Brooke Army Medical Center
mi
from
Fort Sam Houston, TX
Click here to add this to my saved trials
LIPS-B: Lung Injury Prevention Study With Budesonide and Beta
LIPS-B: Lung Injury Prevention Study With Budesonide and Beta Agonist (Formoterol)
Status: Enrolling
Updated:  7/6/2015
University of Arizona
mi
from
Tucson, AZ
LIPS-B: Lung Injury Prevention Study With Budesonide and Beta
LIPS-B: Lung Injury Prevention Study With Budesonide and Beta Agonist (Formoterol)
Status: Enrolling
Updated: 7/6/2015
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
LIPS-B: Lung Injury Prevention Study With Budesonide and Beta
LIPS-B: Lung Injury Prevention Study With Budesonide and Beta Agonist (Formoterol)
Status: Enrolling
Updated:  7/6/2015
Stanford University
mi
from
Stanford, CA
LIPS-B: Lung Injury Prevention Study With Budesonide and Beta
LIPS-B: Lung Injury Prevention Study With Budesonide and Beta Agonist (Formoterol)
Status: Enrolling
Updated: 7/6/2015
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
LIPS-B: Lung Injury Prevention Study With Budesonide and Beta
LIPS-B: Lung Injury Prevention Study With Budesonide and Beta Agonist (Formoterol)
Status: Enrolling
Updated:  7/6/2015
Mayo Clinic Florida
mi
from
Jacksonville, FL
LIPS-B: Lung Injury Prevention Study With Budesonide and Beta
LIPS-B: Lung Injury Prevention Study With Budesonide and Beta Agonist (Formoterol)
Status: Enrolling
Updated: 7/6/2015
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
LIPS-B: Lung Injury Prevention Study With Budesonide and Beta
LIPS-B: Lung Injury Prevention Study With Budesonide and Beta Agonist (Formoterol)
Status: Enrolling
Updated:  7/6/2015
Beth Israel Medical Center
mi
from
Boston, MA
LIPS-B: Lung Injury Prevention Study With Budesonide and Beta
LIPS-B: Lung Injury Prevention Study With Budesonide and Beta Agonist (Formoterol)
Status: Enrolling
Updated: 7/6/2015
Beth Israel Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
LIPS-B: Lung Injury Prevention Study With Budesonide and Beta
LIPS-B: Lung Injury Prevention Study With Budesonide and Beta Agonist (Formoterol)
Status: Enrolling
Updated:  7/6/2015
Mayo Clinic Rochester
mi
from
Rochester, MN
LIPS-B: Lung Injury Prevention Study With Budesonide and Beta
LIPS-B: Lung Injury Prevention Study With Budesonide and Beta Agonist (Formoterol)
Status: Enrolling
Updated: 7/6/2015
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Status: Enrolling
Updated:  7/7/2015
Loma Linda University Medical Center
mi
from
Loma Linda, CA
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Status: Enrolling
Updated: 7/7/2015
Loma Linda University Medical Center
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Status: Enrolling
Updated:  7/7/2015
University of California San Diego Medical Center
mi
from
San Diego, CA
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Status: Enrolling
Updated: 7/7/2015
University of California San Diego Medical Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Status: Enrolling
Updated:  7/7/2015
Maple Grove Hospital
mi
from
Maple Grove, MN
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Status: Enrolling
Updated: 7/7/2015
Maple Grove Hospital
mi
from
Maple Grove, MN
Click here to add this to my saved trials
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Status: Enrolling
Updated:  7/7/2015
University of Minnesota Children's Hospital
mi
from
Minneapolis, MN
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Status: Enrolling
Updated: 7/7/2015
University of Minnesota Children's Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Status: Enrolling
Updated:  7/7/2015
North Memorial Hospital
mi
from
Robbinsdale, MN
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Status: Enrolling
Updated: 7/7/2015
North Memorial Hospital
mi
from
Robbinsdale, MN
Click here to add this to my saved trials
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Status: Enrolling
Updated:  7/7/2015
St Paul Children's Hospital
mi
from
St Paul, MN
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Status: Enrolling
Updated: 7/7/2015
St Paul Children's Hospital
mi
from
St Paul, MN
Click here to add this to my saved trials
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Status: Enrolling
Updated:  7/7/2015
University of Wisconsin-Madison
mi
from
Madison, WI
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
Status: Enrolling
Updated: 7/7/2015
University of Wisconsin-Madison
mi
from
Madison, WI
Click here to add this to my saved trials
Humidified High Flow Nasal Cannula as Compared to Nasal Continuous Positive Airway Pressure
Observational, Cross-over Study of the Positive Distending Pressure Generated by Humidified High Flow Nasal Cannula as Compared to Nasal Continuous Positive Airway Pressure
Status: Enrolling
Updated:  7/13/2015
Childrens Hospital & Clinics of Minnesota
mi
from
Minneapolis, MN
Humidified High Flow Nasal Cannula as Compared to Nasal Continuous Positive Airway Pressure
Observational, Cross-over Study of the Positive Distending Pressure Generated by Humidified High Flow Nasal Cannula as Compared to Nasal Continuous Positive Airway Pressure
Status: Enrolling
Updated: 7/13/2015
Childrens Hospital & Clinics of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Pilot Randomized Controlled Trial for Antibiotic Exposure in Neonatal Sepsis Using Neutrophil CD64
A Pilot Randomized Controlled Trial for Antibiotic Exposure in Neonatal Sepsis Using Neutrophil CD64
Status: Enrolling
Updated:  7/14/2015
Yale-New Haven Children's Hospital NICU
mi
from
New Haven, CT
A Pilot Randomized Controlled Trial for Antibiotic Exposure in Neonatal Sepsis Using Neutrophil CD64
A Pilot Randomized Controlled Trial for Antibiotic Exposure in Neonatal Sepsis Using Neutrophil CD64
Status: Enrolling
Updated: 7/14/2015
Yale-New Haven Children's Hospital NICU
mi
from
New Haven, CT
Click here to add this to my saved trials